Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Microbiote intestinal : qu’en attendre au plan physiologique et thérapeutique ?

Doré J, Multon MC, Béhier JM; les participants à la table ronde 2 des Ateliers de Giens XXXII, Affagard H, Andremont A, Barthélémy P, Batista R, Bonneville M, Bonny C, Boyaval G, Chamaillard M, Chevalier MP, Cordaillat-Simmons M, Cournarie F, Diaz I, Guillaume E, Guyard C, Jouvin-Marche E, Martin FP, Petiteau D.

Therapie. 2017 Feb;72(1):1-19. doi: 10.1016/j.therap.2017.01.001. Epub 2017 Jan 11. French. No abstract available.

PMID:
28214070
2.

Addressing the challenges of chronic viral infections and addiction in prisons: the PRODEPIST study.

Jacomet C, Guyot-Lénat A, Bonny C, Henquell C, Rude M, Dydymski S, Lesturgeon JA, Lambert C, Pereira B, Schmidt J.

Eur J Public Health. 2016 Feb;26(1):122-8. doi: 10.1093/eurpub/ckv183. Epub 2015 Oct 9.

PMID:
26454876
3.

JNK3 is required for the cytoprotective effect of exendin 4.

Ezanno H, Pawlowski V, Abdelli S, Boutry R, Gmyr V, Kerr-Conte J, Bonny C, Pattou F, Abderrahmani A.

J Diabetes Res. 2014;2014:814854. doi: 10.1155/2014/814854. Epub 2014 Jun 16.

4.

Regulation of the JNK3 signaling pathway during islet isolation: JNK3 and c-fos as new markers of islet quality for transplantation.

Abdelli S, Papas KK, Mueller KR, Murtaugh MP, Hering BJ, Bonny C.

PLoS One. 2014 Jul 1;9(7):e99796. doi: 10.1371/journal.pone.0099796. eCollection 2014.

5.

The nNOS-p38MAPK pathway is mediated by NOS1AP during neuronal death.

Li LL, Ginet V, Liu X, Vergun O, Tuittila M, Mathieu M, Bonny C, Puyal J, Truttmann AC, Courtney MJ.

J Neurosci. 2013 May 8;33(19):8185-201. doi: 10.1523/JNEUROSCI.4578-12.2013.

6.

Role of JNK isoforms in the development of neuropathic pain following sciatic nerve transection in the mouse.

Manassero G, Repetto IE, Cobianchi S, Valsecchi V, Bonny C, Rossi F, Vercelli A.

Mol Pain. 2012 May 22;8:39. doi: 10.1186/1744-8069-8-39.

7.
8.

The JNK inhibitor D-JNKI-1 blocks apoptotic JNK signaling in brain mitochondria.

Zhao Y, Spigolon G, Bonny C, Culman J, Vercelli A, Herdegen T.

Mol Cell Neurosci. 2012 Mar;49(3):300-10. doi: 10.1016/j.mcn.2011.12.005. Epub 2011 Dec 21.

PMID:
22206897
9.

A randomized controlled trial of endoscopist vs. anaesthetist-administered sedation for colonoscopy.

Poincloux L, Laquière A, Bazin JE, Monzy F, Artigues F, Bonny C, Abergel A, Dapoigny M, Bommelaer G.

Dig Liver Dis. 2011 Jul;43(7):553-8. doi: 10.1016/j.dld.2011.02.007. Epub 2011 Mar 29.

PMID:
21450542
10.

Non-invasive assessment of liver fibrosis progression in hepatitis C patients retreated for 96 weeks with antiviral therapy: a randomized study.

Zarski JP, Sturm N, Desmorat H, Melin P, Raabe JJ, Bonny C, Sogni P, Pinta A, Rouanet S, Babany G, Cheveau A, Chevallier M.

Liver Int. 2010 Aug;30(7):1049-58. doi: 10.1111/j.1478-3231.2010.02265.x. Epub 2010 May 21.

PMID:
20492512
11.

c-Jun N-terminal kinase pathway inhibition in intracerebral hemorrhage.

Michel-Monigadon D, Bonny C, Hirt L.

Cerebrovasc Dis. 2010;29(6):564-70. doi: 10.1159/000306643. Epub 2010 Apr 8.

PMID:
20375499
12.

c-Jun N-terminal kinase signaling pathway in excitotoxic cell death following kainic acid-induced status epilepticus.

Spigolon G, Veronesi C, Bonny C, Vercelli A.

Eur J Neurosci. 2010 Apr;31(7):1261-72. doi: 10.1111/j.1460-9568.2010.07158.x. Epub 2010 Mar 24.

PMID:
20345908
13.

Role of the c-Jun N-terminal kinase pathway in retinal excitotoxicity, and neuroprotection by its inhibition.

Bessero AC, Chiodini F, Rungger-Brändle E, Bonny C, Clarke PG.

J Neurochem. 2010 Jun;113(5):1307-18. doi: 10.1111/j.1471-4159.2010.06705.x. Epub 2010 Mar 25.

14.

JNK inhibition and inflammation after cerebral ischemia.

Benakis C, Bonny C, Hirt L.

Brain Behav Immun. 2010 Jul;24(5):800-11. doi: 10.1016/j.bbi.2009.11.001. Epub 2009 Nov 10.

PMID:
19903520
15.

The c-Jun N-terminal kinase (JNK) inhibitor XG-102 enhances the neuroprotection of hyperbaric oxygen after cerebral ischaemia in adult rats.

Liu JR, Zhao Y, Patzer A, Staak N, Boehm R, Deuschl G, Culman J, Bonny C, Herdegen T, Eschenfelder C.

Neuropathol Appl Neurobiol. 2010 Apr;36(3):211-24. doi: 10.1111/j.1365-2990.2009.01047.x. Epub 2009 Oct 22.

PMID:
19849792
16.

JNK3 is abundant in insulin-secreting cells and protects against cytokine-induced apoptosis.

Abdelli S, Puyal J, Bielmann C, Buchillier V, Abderrahmani A, Clarke PG, Beckmann JS, Bonny C.

Diabetologia. 2009 Sep;52(9):1871-80. doi: 10.1007/s00125-009-1431-7. Epub 2009 Jul 16.

PMID:
19609503
17.

c-Jun N-terminal kinase binding domain-dependent phosphorylation of mitogen-activated protein kinase kinase 4 and mitogen-activated protein kinase kinase 7 and balancing cross-talk between c-Jun N-terminal kinase and extracellular signal-regulated kinase pathways in cortical neurons.

Repici M, Mare L, Colombo A, Ploia C, Sclip A, Bonny C, Nicod P, Salmona M, Borsello T.

Neuroscience. 2009 Mar 3;159(1):94-103. doi: 10.1016/j.neuroscience.2008.11.049. Epub 2008 Dec 14.

PMID:
19135136
18.

The JNK inhibitor XG-102 protects from ischemic damage with delayed intravenous administration also in the presence of recombinant tissue plasminogen activator.

Wiegler K, Bonny C, Coquoz D, Hirt L.

Cerebrovasc Dis. 2008;26(4):360-6. doi: 10.1159/000151639. Epub 2008 Aug 27.

PMID:
18728363
19.

Modulation of the c-Jun N-terminal kinase activity in the embryonic heart in response to anoxia-reoxygenation: involvement of the Ca2+ and mitoKATP channels.

Sarre A, Gardier S, Maurer F, Bonny C, Raddatz E.

Mol Cell Biochem. 2008 Jun;313(1-2):133-8. doi: 10.1007/s11010-008-9750-4. Epub 2008 Apr 17.

PMID:
18418700
20.

Glucose and leptin induce apoptosis in human beta-cells and impair glucose-stimulated insulin secretion through activation of c-Jun N-terminal kinases.

Maedler K, Schulthess FT, Bielman C, Berney T, Bonny C, Prentki M, Donath MY, Roduit R.

FASEB J. 2008 Jun;22(6):1905-13. doi: 10.1096/fj.07-101824. Epub 2008 Feb 8.

21.

D-JNKi, a peptide inhibitor of c-Jun N-terminal kinase, promotes functional recovery after transient focal cerebral ischemia in rats.

Esneault E, Castagne V, Moser P, Bonny C, Bernaudin M.

Neuroscience. 2008 Mar 18;152(2):308-20. doi: 10.1016/j.neuroscience.2007.12.036. Epub 2008 Jan 4.

PMID:
18262367
22.

Time-course of c-Jun N-terminal kinase activation after cerebral ischemia and effect of D-JNKI1 on c-Jun and caspase-3 activation.

Repici M, Centeno C, Tomasi S, Forloni G, Bonny C, Vercelli A, Borsello T.

Neuroscience. 2007 Nov 30;150(1):40-9. Epub 2007 Aug 28.

PMID:
17900813
23.

The epidemiology and virology of hepatitis C virus genotype 5 in central France.

Abergel A, Ughetto S, Dubost S, Bonny C, Aublet-Cuvelier B, Delarocque-Astagneau E, Bailly JL, Bommelaer G, Casanova S, Delteil J, Deny P, Laurichesse H, Odent-Malaure H, Roussel J, Peigue-Lafeuille H, Henquell C.

Aliment Pharmacol Ther. 2007 Nov 15;26(10):1437-46. Epub 2007 Sep 26.

24.

Cell-permeable peptides induce dose- and length-dependent cytotoxic effects.

Cardozo AK, Buchillier V, Mathieu M, Chen J, Ortis F, Ladrière L, Allaman-Pillet N, Poirot O, Kellenberger S, Beckmann JS, Eizirik DL, Bonny C, Maurer F.

Biochim Biophys Acta. 2007 Sep;1768(9):2222-34. Epub 2007 Jun 14.

25.

The c-Jun N-terminal kinase JNK participates in cytokine- and isolation stress-induced rat pancreatic islet apoptosis.

Abdelli S, Abderrahmani A, Hering BJ, Beckmann JS, Bonny C.

Diabetologia. 2007 Aug;50(8):1660-9. Epub 2007 Jun 9.

PMID:
17558486
26.

Novel strategy for treatment of viral central nervous system infection by using a cell-permeating inhibitor of c-Jun N-terminal kinase.

Beckham JD, Goody RJ, Clarke P, Bonny C, Tyler KL.

J Virol. 2007 Jul;81(13):6984-92. Epub 2007 May 2.

27.

[Iron overload and chronic liver diseases].

Abergel A, Ruivard M, Bonny C.

Rev Prat. 2006 Dec 15;56(19):2130-4. French.

PMID:
17416050
28.

A peptide inhibitor of c-Jun NH2-terminal kinase reduces myocardial ischemia-reperfusion injury and infarct size in vivo.

Milano G, Morel S, Bonny C, Samaja M, von Segesser LK, Nicod P, Vassalli G.

Am J Physiol Heart Circ Physiol. 2007 Apr;292(4):H1828-35. Epub 2006 Dec 8.

29.

Inhibition of the c-Jun N-terminal kinase-mediated mitochondrial cell death pathway restores auditory function in sound-exposed animals.

Wang J, Ruel J, Ladrech S, Bonny C, van de Water TR, Puel JL.

Mol Pharmacol. 2007 Mar;71(3):654-66. Epub 2006 Nov 28.

PMID:
17132689
30.

Peginterferon alpha-2b plus ribavirin for treatment of chronic hepatitis C with severe fibrosis: a multicentre randomized controlled trial comparing two doses of peginterferon alpha-2b.

Abergel A, Hezode C, Leroy V, Barange K, Bronowicki JP, Tran A, Alric L, Castera L, Bernard PH, Henquell C, Lafeuille H, Ughetto S, Darcha C, Chevallier M, Martineau N, Dubost S, Randl K, Dhumeaux D, Bommelaer G, Bonny C; French multicenter study group.

J Viral Hepat. 2006 Dec;13(12):811-20.

PMID:
17109680
31.

Blocking c-Jun-N-terminal kinase signaling can prevent hearing loss induced by both electrode insertion trauma and neomycin ototoxicity.

Eshraghi AA, Wang J, Adil E, He J, Zine A, Bublik M, Bonny C, Puel JL, Balkany TJ, Van De Water TR.

Hear Res. 2007 Apr;226(1-2):168-77. Epub 2006 Nov 13.

PMID:
17098385
32.

Homogeneous and nonradioactive high-throughput screening platform for the characterization of kinase inhibitors in cell lysates.

Guenat S, Rouleau N, Bielmann C, Bedard J, Maurer F, Allaman-Pillet N, Nicod P, Bielefeld-Sévigny M, Beckmann JS, Bonny C, Bossé R, Roduit R.

J Biomol Screen. 2006 Dec;11(8):1015-26. Epub 2006 Nov 7.

PMID:
17092917
33.

Blocking stress signaling pathways with cell permeable peptides.

Bonny C.

Adv Exp Med Biol. 2006;588:133-43. Review.

PMID:
17089885
34.

Effectiveness of interferon plus ribavirin combination in the treatment of naive patients with hepatitis C virus type 5. A French multicentre retrospective study.

Bonny C, Fontaine H, Poynard T, Hézode C, Larrey D, Marcellin P, Bourlière M, Bronowicki JP, Merle P, Zarski JP, Sapey T, Guillemard C, Ughetto S, Henquell C, Nicolas C, Roche C, Randl K, Bommelaer G, Abergel A.

Aliment Pharmacol Ther. 2006 Aug 15;24(4):593-600. Erratum in: Aliment Pharmacol Ther. 2006 Oct 15;24(8):1268.

35.

Role of the JNK pathway in NMDA-mediated excitotoxicity of cortical neurons.

Centeno C, Repici M, Chatton JY, Riederer BM, Bonny C, Nicod P, Price M, Clarke PG, Papa S, Franzoso G, Borsello T.

Cell Death Differ. 2007 Feb;14(2):240-53. Epub 2006 Jun 23.

36.

D-JNKI-1 treatment prevents the progression of hearing loss in a model of cochlear implantation trauma.

Eshraghi AA, He J, Mou CH, Polak M, Zine A, Bonny C, Balkany TJ, Van De Water TR.

Otol Neurotol. 2006 Jun;27(4):504-11.

PMID:
16791042
37.

Brief reoxygenation episodes during chronic hypoxia enhance posthypoxic recovery of LV function: role of mitogen-activated protein kinase signaling pathways.

Morel S, Milano G, Ludunge KM, Corno AF, Samaja M, Fleury S, Bonny C, Kappenberger L, von Segesser LK, Vassalli G.

Basic Res Cardiol. 2006 Jul;101(4):336-45. Epub 2006 May 16.

PMID:
16705469
39.

Significance of patient-controlled sedation during colonoscopy. Results from a prospective randomized controlled study.

Crepeau T, Poincloux L, Bonny C, Lighetto S, Jaffeux P, Artigue F, Walleckx P, Bazin JE, Dapoigny M, Bommelaer G.

Gastroenterol Clin Biol. 2005 Nov;29(11):1090-6.

40.

A unique set of SH3-SH3 interactions controls IB1 homodimerization.

Kristensen O, Guenat S, Dar I, Allaman-Pillet N, Abderrahmani A, Ferdaoussi M, Roduit R, Maurer F, Beckmann JS, Kastrup JS, Gajhede M, Bonny C.

EMBO J. 2006 Feb 22;25(4):785-97. Epub 2006 Feb 2.

41.

Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid: a randomised controlled pilot trail.

Moreau R, Valla DC, Durand-Zaleski I, Bronowicki JP, Durand F, Chaput JC, Dadamessi I, Silvain C, Bonny C, Oberti F, Gournay J, Lebrec D, Grouin JM, Guémas E, Golly D, Padrazzi B, Tellier Z.

Liver Int. 2006 Feb;26(1):46-54.

PMID:
16420509
42.

D-TAT transporter as an ocular peptide delivery system.

Schorderet DF, Manzi Vd, Canola K, Bonny C, Arsenijevic Y, Munier FL, Maurer F.

Clin Exp Ophthalmol. 2005 Dec;33(6):628-35.

PMID:
16402957
43.

Extracellular signal-regulated kinase is essential for interleukin-1-induced and nuclear factor kappaB-mediated gene expression in insulin-producing INS-1E cells.

Larsen L, Størling J, Darville M, Eizirik DL, Bonny C, Billestrup N, Mandrup-Poulsen T.

Diabetologia. 2005 Dec;48(12):2582-90. Epub 2005 Nov 11.

PMID:
16283237
44.

[Role of intracellular signalling pathways in the development of type 1 diabetes].

Bonny C.

Rev Med Suisse. 2005 Apr 27;1(17):1153-6. French.

PMID:
15941087
45.

Targeting the JNK pathway as a therapeutic protective strategy for nervous system diseases.

Bonny C, Borsello T, Zine A.

Rev Neurosci. 2005;16(1):57-67. Review.

PMID:
15810654
46.

Antitumorigenic effect of proteasome inhibitors on insulinoma cells.

Størling J, Allaman-Pillet N, Karlsen AE, Billestrup N, Bonny C, Mandrup-Poulsen T.

Endocrinology. 2005 Apr;146(4):1718-26. Epub 2004 Dec 23.

PMID:
15618349
47.

Intracellular stress signaling pathways activated during human islet preparation and following acute cytokine exposure.

Abdelli S, Ansite J, Roduit R, Borsello T, Matsumoto I, Sawada T, Allaman-Pillet N, Henry H, Beckmann JS, Hering BJ, Bonny C.

Diabetes. 2004 Nov;53(11):2815-23.

48.

Histological response in patients treated by interferon plus ribavirin for hepatitis C virus-related severe fibrosis.

Abergel A, Darcha C, Chevallier M, Ughetto S, Henquell C, Pol S, de Ledinghen V, Canva V, Bronowicki JP, Tran A, Martineau N, Lafeuille H, Dechelotte P, Bommelaer G, Bonny C; French Multicentre Study Group.

Eur J Gastroenterol Hepatol. 2004 Nov;16(11):1219-27.

PMID:
15489585
49.

Circadian regulation of islet genes involved in insulin production and secretion.

Allaman-Pillet N, Roduit R, Oberson A, Abdelli S, Ruiz J, Beckmann JS, Schorderet DF, Bonny C.

Mol Cell Endocrinol. 2004 Oct 29;226(1-2):59-66.

PMID:
15489006
50.

A RasGAP-derived cell permeable peptide potently enhances genotoxin-induced cytotoxicity in tumor cells.

Michod D, Yang JY, Chen J, Bonny C, Widmann C.

Oncogene. 2004 Nov 25;23(55):8971-8.

PMID:
15467750

Supplemental Content

Support Center